Milan, Italy

Franco Faustini

This inventor holds 25 USPTO granted patents, primarily in Prostaglandin Derivatives. Top assignees: Farmitalia Carlo Erba, Carlo Erba, Farmitalia Carlo Erba S.r.l.. Active years: 1980-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franco Faustini. Retrieved from https://idiyas.com/inventor/franco-faustini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 1980-1989

Loading Chart...
Areas of Expertise:
Prostaglandins
Bicyclic Compounds
Steroidic Inhibitors
Pharmaceutical Composition
Alkynylestrene Derivatives
Thiacyclic Compounds
Dehydro-Prostaglandins
Ester Derivatives
Aromatase Inhibitors
Fluoro-Prostaglandins
Androstendione Derivatives
PGI Compounds
25 patents (USPTO):Explore Patents

Title: **Franco Faustini: A Pioneer in Pharmaceutical Innovations**

Introduction

Franco Faustini is a prominent inventor based in Milan, Italy, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 25 patents, Faustini has focused his research on developing innovative compounds that serve crucial therapeutic purposes, particularly in treating hormone-dependent conditions.

Latest Patents

Among his latest patents are two notable inventions. The first is related to **6-Alkylidene 10.beta.-alkynylestrene derivatives**. This invention encompasses a range of 6-substituted 10.beta.-alkynylestrene derivatives where the 6 substituents may include amino, azido, halogen, or an alkylidene group. Furthermore, it introduces a process for synthesizing these compounds and pharmaceutical compositions, which are recognized as effective aromatase inhibitors beneficial for the treatment of hormone-dependent tumors and prostatic hyperplasia.

The second patent addresses **steroidic aromatase inhibitors**, specifically focusing on 6-substituted androsta-1,4-diene-3,17-dione derivatives. Similar to his earlier work, this invention includes compounds with azido, amino, or substituted amino groups. The process for preparing these compounds and their corresponding pharmaceutical compositions is also detailed, highlighting their utility in combating hormone-dependent tumors.

Career Highlights

Throughout his illustrious career, Franco Faustini has made impactful contributions to the pharmaceutical industry. He has worked with reputable companies like **Farmitalia Carlo Erba S.p.a.** and **Farmitalia Carlo Erba S.r.l.**, where he dedicated his expertise towards innovative drug development.

Collaborations

In his journey, Faustini has collaborated with several distinguished colleagues, including Carmelo Gandolfi and Angelo Fumagalli. Their combined efforts have propelled advancements in pharmaceutical research, further illustrating the collaborative nature of innovation in this field.

Conclusion

Franco Faustini stands as a testament to the innovative spirit that drives pharmaceutical research forward. With 25 patents to his name and a commitment to developing effective treatments for critical health issues, his contributions continue to resonate within the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…